2019 QCDR measures

AAD QCDR ID Measure name Description Steward Type of measure NQS Domain
 AAD 2 Psoriasis: Screening for Psoriatic Arthritis
Percentage of patients with diagnosis of psoriasis that are screened for psoriatic arthritis at least once during the performance period.
 AAD Process  Person & Caregiver-Centered
Experience
Outcomes
 
AAD 5
Biopsy: Reporting Time - Clinician to Patient
Percentage of patients with skin biopsy specimens with a diagnosis of cutaneous basal or squamous cell carcinoma (including in situ disease) who are notified of their final biopsy pathology findings within less than or equal to 14 days from the time the biopsy was performed.

 AAD Process
Communication & Care Coordination
ACMS 1 Adherence to Mohs Micrographic Surgery Appropriate Use Criteria
Percentage of Mohs micrographic surgery cases that meet criteria according to published Mohs surgery appropriate use criteria (AUC) guidelines.
American College of Mohs Surgeons
Efficiency & Cost/Resource Use
Efficiency & Cost Reduction


©American Academy of Dermatology/Association. All rights reserved. The American Academy of Dermatology and the American Academy of Dermatology Association (collectively AAD/A) own all right, title, and interest in the quality measures presented on these web pages. These quality measures are provided solely for the benefit of AAD/A and its members for the purposes specified herein and for other AAD/A purposes. They may not be used by other parties except with prior written approval of the AAD/A.